Artificial tears are over-the-counter lubricating eye drops that replicate the function of natural tears, providing relief from dry eye syndrome by supplementing the aqueous, lipid, or mucin layers of the tear film. They are widely used to relieve eye dryness, irritation, and discomfort caused by prolonged screen use or contact lens wear.

Artificial Tears Market Overview and Growth Outlook

The global artificial tears market is projected to grow significantly in the coming years. Valued at US$ 2.98 billion in 2023, the market is expected to reach US$ 4.85 billion by 2031, growing at a CAGR of 7.2% during 2024–2031. Factors such as increasing prevalence of dry eye conditions, changing lifestyle habits, and a growing elderly population are driving this growth.

Dry eye conditions are particularly common in developed countries, influenced by environmental factors, extended screen exposure, and other lifestyle-related causes. According to the US National Health and Wellness Survey (2020), approximately 16.4 million people were diagnosed with dry eye. Among individuals aged 18–34 years, prevalence increased by 2.7%, while older adults showed a prevalence of 18.6%. Women are more affected than men, with rates of 8.8% versus 4.5%, respectively. Similar trends in Europe and Asia Pacific underscore the strong demand for artificial tear products.

Key Market Drivers

  • Aging Population

The global geriatric population is expanding rapidly. By 2050, one in six people worldwide will be over 65, compared to one in eleven in 2019. In Europe and North America, projections indicate that one in four people will be over 65 by 2050. Additionally, the population aged 80 and above is expected to rise from 143 million in 2019 to 426 million by 2050. Aging increases susceptibility to eye conditions such as dry eye, encouraging manufacturers to develop targeted solutions for older adults, fueling market growth.

  • Product Innovations and Industrial Developments

The market is witnessing frequent innovations and strategic product launches:

  • Grafton Optical launched I-DROP MGD Viscoadaptive Tears (March 2020), a preservative-free option for patients with Meibomian Gland Dysfunction.
  • Alcon introduced SYSTANE HYDRATION Preservative-Free Lubricant Eye Drops, designed to relieve dryness and irritation.
  • Allergan launched Refresh Relieva lubricant eye drops in October 2019.
  • Sun Pharma released CEQUA in India (April 2023) for dry eye disease treatment.

These innovations, particularly preservative-free and therapeutic formulations, are enhancing product appeal and driving market growth.

Download PDF Copy- https://www.theinsightpartners.com/sample/TIPRE00004073 

Market Segmentation

By Type:

  • Cellulose derived tears
  • Glycerin derived tears (largest share in 2023)
  • Oil-based emulsion tears
  • Polyethylene glycol-based tears

By Delivery Mode:

  • Eye drops
  • Ointments

By Application:

  • Dry eyes treatment (largest segment in 2023)
  • Contact lenses moisture

Regional Insights

North America leads the market, with the US being the largest contributor due to high prevalence of dry eye, growing healthcare expenditure, and availability of advanced eye care products. According to JAMA Internal Medicine, the US government spends over US$ 2 billion annually on dry eye treatment. Europe and Asia Pacific are also high-growth regions due to aging populations and increasing awareness of eye health.

Key Players

The artificial tears market is highly competitive, with leading companies focusing on innovation, strategic partnerships, and regional expansion:

  • Johnson Services, Inc.
  • Alcon Inc.
  • OASIS Medical
  • AbbVie Inc.
  • Bayer AG
  • Prestige Consumer Healthcare Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Bausch Health Companies Inc.
  • Akorn Incorporated
  • Aurolab

Future Outlook

The artificial tears market is expected to maintain steady growth through 2031. Rising screen time, widespread smartphone use, and lifestyle-related eye disorders will continue to drive demand. Advancements in formulation technology, including preservative-free and long-lasting lubricating drops, will improve efficacy and user compliance. Expanding markets in Asia Pacific, Latin America, and the Middle East, along with new product launches and strategic collaborations, are likely to create significant growth opportunities for market participants.

Related Reports-

Skin Tears Treatment Market

Artificial Joints Market